| Effect of nesiritide in patients with acute decompensated heart failure CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ... New England Journal of Medicine 365 (1), 32-43, 2011 | 1456 | 2011 |
| Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular … JB Young, ME Dunlap, MA Pfeffer, JL Probstfield, A Cohen-Solal, R Dietz, ... Circulation 110 (17), 2618-2626, 2004 | 454 | 2004 |
| Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study MM Givertz, KJ Anstrom, MM Redfield, A Deswal, H Haddad, J Butler, ... Circulation 131 (20), 1763-1771, 2015 | 323 | 2015 |
| Characterization of health‐related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM EF Lewis, GA Lamas, E O'Meara, CB Granger, ME Dunlap, RS McKelvie, ... European journal of heart failure 9 (1), 83-91, 2007 | 322 | 2007 |
| Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation C Fallick, PA Sobotka, ME Dunlap Circulation: Heart Failure 4 (5), 669-675, 2011 | 316 | 2011 |
| Pulsatile hemodynamics in congestive heart failure GF Mitchell, JC Tardif, JMO Arnold, G Marchiori, TX O’Brien, ME Dunlap, ... Hypertension 38 (6), 1433-1439, 2001 | 256 | 2001 |
| Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) A Hjalmarson, S Goldstein, B Fagerberg, H Wedel, F Waagstein, ... Lancet 353 (9169), 2001-2007, 1999 | 251 | 1999 |
| 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure DE Forman, JL Fleg, DW Kitzman, CA Brawner, AM Swank, RS McKelvie, ... Journal of the American College of Cardiology 60 (25), 2653-2661, 2012 | 234 | 2012 |
| Aortic diameter, wall stiffness, and wave reflection in systolic hypertension GF Mitchell, PR Conlin, ME Dunlap, Y Lacourcière, JMO Arnold, ... Hypertension 51 (1), 105-111, 2008 | 220 | 2008 |
| Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program AS Desai, K Swedberg, JJV McMurray, CB Granger, S Yusuf, JB Young, ... Journal of the American College of Cardiology 50 (20), 1959-1966, 2007 | 198 | 2007 |
| Ganglionic mechanisms contribute to diminished vagal control in heart failure S Bibevski, ME Dunlap Circulation 99 (22), 2958-2963, 1999 | 157 | 1999 |
| Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Investigators and Committees. Mortality and morbidity reduction with Candesartan in … Y JB Circulation 110 (17), 2618-2626, 2004 | 134 | 2004 |
| DITPA (3, 5-diiodothyropropionic acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study S Goldman, M McCarren, E Morkin, PW Ladenson, R Edson, S Warren, ... Circulation 119 (24), 3093-3100, 2009 | 131 | 2009 |
| Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy GF Mitchell, ME Dunlap, W Warnica, A Ducharme, JMO Arnold, JC Tardif, ... Hypertension 49 (6), 1271-1277, 2007 | 130 | 2007 |
| The heart failure clinic: a consensus statement of the Heart Failure Society of America PJ Hauptman, MW Rich, PA Heidenreich, J Chin, N Cummings, ... Journal of cardiac failure 14 (10), 801-815, 2008 | 127 | 2008 |
| Effect of treatment with sacubitril/valsartan in patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial DL Mann, MM Givertz, JM Vader, RC Starling, P Shah, SE McNulty, ... JAMA cardiology 7 (1), 17-25, 2022 | 114 | 2022 |
| Body weight change during and after hospitalization for acute heart failure: patient characteristics, markers of congestion, and outcomes: findings from the ASCEND-HF trial AP Ambrosy, LP Cerbin, PW Armstrong, J Butler, A Coles, AD DeVore, ... JACC: Heart Failure 5 (1), 1-13, 2017 | 113 | 2017 |
| Evidence for impaired vagus nerve activity in heart failure S Bibevski, ME Dunlap Heart failure reviews 16, 129-135, 2011 | 113 | 2011 |
| Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity ME Dunlap, S Bibevski, TL Rosenberry, P Ernsberger American Journal of Physiology-Heart and Circulatory Physiology 285 (4 …, 2003 | 96 | 2003 |
| Functional nicotinic acetylcholine receptors that mediate ganglionic transmission in cardiac parasympathetic neurons S Bibevski, Y Zhou, JM McIntosh, RE Zigmond, ME Dunlap Journal of Neuroscience 20 (13), 5076-5082, 2000 | 94 | 2000 |
